ZhenGe Biotech’s $51 Million Series A Financing Round

Michael Patrini

Jones Day represented Shanghai Zhenge Biotech Co., Ltd. in the transaction. Shanghai ZhenGe Biotechnology Co.,Ltd. (“ZhenGe Biotech”) , a Chinese macromolecular pharmaceutical contract development and manufacturing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here